Yongye Biotechnology International (NASDAQ:YONG.DL)

CAPS Rating: No stars

The company develops, manufactures, and distributes fulvic-acid-based nutrient compounds for plant and animal feed in China.

Recs

8
Player Avatar ws6transam84 (40.93) Submitted: 5/31/2011 11:38:45 AM : Outperform Start Price: $3.85 YONG.DL Score: -21.66

Like it or not, all signals point to China as being one of the great new markets of the 21st century. It's currently the wild west. Many businesses will fold and many others will thrive. Some are shams and many are the real-deal. This one looks genuine to me. Morgan Stanley appears to agree with this assessment, and has invested $50M. Analysts with financially vested interests (shorts) managed to scare the share price down in order to make a profit. Yongye CEO is also putting in $3M and increasing his holdings of common stock. That would indicate he's somewhat confident in the product. Nothing is for sure in China but Yongye seems to offer at least some measure of success.

Report this Post 3 Replies
Member Avatar rganesh09 (54.03) Submitted: 5/31/2011 11:44:29 AM
Recs: 0

The markets seem to like it .... Let us hope the climb continues.

Member Avatar Fundamentalisten (< 20) Submitted: 7/2/2011 4:04:54 AM
Recs: 0

Should double in à year! I have followed this stock a year and quadroupled My holdings on the way, and I Will keep on investing more and more as long as they keep on expanding this exciting business in this profitable way!

Member Avatar mardukkorn (73.84) Submitted: 10/27/2011 5:52:05 AM
Recs: 0

Does not pay a dividend.
That is the most important safety check for Chinese companies.

Featured Broker Partners


Advertisement